Phase I clinical, biology & pharmacokinetic study of the combination of GW 572016 and capecitabine in patients with advanced solid tumors

被引：0
|
作者：
Schwartz, G
Chu, QSC
Hammond, LA
Mita, M
Curtright, J
Versola, MJ
Koch, K
Pandite, LN
Ho, PTC
Rowinsky, EK
机构：
[1] Brooke Army Med Ctr, San Antonio, TX USA
[2] Inst Drug Dev, San Antonio, TX USA
[3] GlaxoSmithKline, Res Triangle Pk, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3070
引用
收藏
页码：212S / 212S
页数：1
相关论文
共 50 条
  • [41] A phase I and pharmacokinetic study of exisulind and docetaxel in patients with advanced solid tumors
    Witta, SE
    Gustafson, DL
    Pierson, AS
    Menter, A
    Holden, SN
    Basche, M
    Persky, M
    O'Bryant, CL
    Zeng, C
    Baron, A
    Long, ME
    Gibbs, A
    Kelly, K
    Bunn, PA
    Chan, DC
    Pallansch, P
    Eckhardt, SG
    CLINICAL CANCER RESEARCH, 2004, 10 (21) : 7229 - 7237
  • [42] A phase I and pharmacokinetic study of losoxantrone and paclitaxel in patients with advanced solid tumors
    Diab, SG
    Baker, SD
    Joshi, A
    Burris, HA
    Cobb, PW
    Villalona-Calero, RA
    Eckhardt, SG
    Weiss, GR
    Rodriguez, GI
    Drengler, R
    Kraynak, M
    Hammond, L
    Finizio, M
    Von Hoff, DD
    Rowinsky, EK
    CLINICAL CANCER RESEARCH, 1999, 5 (02) : 299 - 308
  • [43] Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with advanced solid malignancies
    H. Sayar
    Z. Shen
    S. J. Lee
    M. Royce
    I. Rabinowitz
    F. Lee
    H. Smith
    S. Eberhardt
    A. Maestas
    H. Lu
    C. Verschraegen
    Investigational New Drugs, 2009, 27 : 153 - 158
  • [44] UFT in combination with oxaliplatin:: clinical phase I study in patients with advanced or metastatic solid tumors
    Sastre, Javier
    Aranda, Enrique
    Abad, Albert
    Gallego, Javier
    Luis Manzano, Jose
    Gomez, Auxiliadora
    Carrato, Alfredo
    Lopez, Eva
    Diaz-Rubio, Eduardo
    ANTI-CANCER DRUGS, 2006, 17 (04) : 417 - 421
  • [45] Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with advanced solid malignancies
    Sayar, H.
    Shen, Z.
    Lee, S. J.
    Royce, M.
    Rabinowitz, I.
    Lee, F.
    Smith, H.
    Eberhardt, S.
    Maestas, A.
    Lu, H.
    Verschraegen, C.
    INVESTIGATIONAL NEW DRUGS, 2009, 27 (02) : 153 - 158
  • [46] Phase I clinical and pharmacokinetic study of oral S-1 in patients with advanced solid tumors
    van Groeningen, CJ
    Peters, GJ
    Schornagel, JH
    Gall, H
    Noordhuis, P
    de Vries, MJ
    Turner, SL
    Swart, MS
    Pinedo, HM
    Hanauske, AR
    Giaccone, G
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (14) : 2772 - 2779
  • [47] A phase I dose-escalation and pharmacokinetic study of sunitinib in combination with docetaxel in patients with advanced solid tumors
    Robert, F.
    Sandler, A.
    Schiller, J. H.
    Ilagan, J.
    Harper, K.
    Vermeulen, W.
    Liu, G.
    Tye, L.
    Chao, R.
    Verkh, L.
    Traynor, A.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3514S - 3515S
  • [48] Phase I pharmacokinetic (PK) study of daily imatinib in combination with docetaxel for patients with advanced solid tumors.
    Chatta, GS
    Fakih, M
    Ramalingam, S
    Belani, CP
    Ramanathan, RK
    Zamboni, N
    Friedland, D
    Lis, D
    Tutchko, S
    Egorin, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 138S - 138S
  • [49] Phase I clinical and pharmacokinetic study of irinotecan, fluorouracil, anti leucovorin in patients with advanced solid tumors
    Saltz, LB
    Kanowitz, J
    Kemeny, NE
    Schaaf, L
    Spriggs, D
    Staton, BA
    Berkery, R
    Steger, C
    Eng, M
    Dietz, A
    Locker, P
    Kelsen, DP
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (11) : 2959 - 2967
  • [50] A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors
    Fakih, Marwan G.
    Trump, Donald L.
    Muindi, Josephia R.
    Black, Jennifer D.
    Bernardi, Ronald J.
    Creaven, Patrick J.
    Schwartz, James
    Brattain, Michael G.
    French, Renee
    Johnson, Candance S.
    CLINICAL CANCER RESEARCH, 2007, 13 (04) : 1216 - 1223
12345